cancer
Another legal blow to Bayer in Roundup litigation
The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.
Monsanto on trial again – Missouri Roundup case begins
Nearly four years after the first-ever trial over allegations that exposure to Roundup herbicide causes cancer a new trial was underway on Tuesday, pitting a 34-year-old man suffering from non-Hodgkin lymphoma (NHL) against Monsanto owner Bayer AG.
Interview: Lawyer Rob Bilott on PFAS “worldwide public health threat” and his letter to President Biden
Last month, an Ohio court certified a class action lawsuit brought by lawyer Rob Bilott that would cover seven million people – and at some point potentially everyone living in the United States – who have been exposed to certain hazardous chemicals known as Per- and Polyfluoroalkyl Substances or PFAS.
Former Monsanto CEO could have to testify at upcoming Roundup trial
Former Monsanto CEO Hugh Grant lost his appeal to escape testifying at an upcoming trial over claims that the company’s Roundup herbicide causes cancer.
California regulators changing language on glyphosate and cancer risk
The California Office of Environmental Health Hazard Assessment (OEHHA) is proposing changes to its messaging to consumers regarding the cancer risk associated with products made with the weed killing chemical glyphosate.
Former Monsanto CEO files for protective order in Roundup case
Former Monsanto Co. Chairman and CEO Hugh Grant is appealing a judge’s order that would allow lawyers for a cancer patient to question him on the stand in a trial scheduled to start next month in Kansas City.
St. Louis Roundup trial is off; parties settle
Just days before the scheduled start of what would have been the first Roundup cancer trial to take place in St. Louis, the former hometown of Monsanto Co., the three plaintiffs in the case on Wednesday agreed to accept a settlement offer from the maker of Roundup herbicide, which the plaintiffs alleged caused them each to develop non-Hodgkin lymphoma.
Monsanto seeks “emergency” delay for St. Louis trial
Monsanto on Thursday asked a St. Louis judge to delay the start of a trial over claims brought by three men alleging exposure to Monsanto’s glyphosate-based herbicides, such as the popular Roundup brand, caused them to develop non-Hodgkin lymphoma.
Unsettled – Another Monsanto Roundup case heads to trial
Three people suffering from cancer are set to face off against Monsanto in the latest courtroom battle over allegations that exposure to the company’s Roundup weed killer causes non-Hodgkin lymphoma.
